Project Details
Description
DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
| Status | Active |
|---|---|
| Effective start/end date | 12/23/20 → 12/31/26 |
Funding
- PROSTATE CANCER CLINTRIAL CONSORTIUM LLC
- MEMORIAL SLOAN-KETTERING CANCER CENTER
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.